In a student loan market saturated with first-pass credit decisions and rigid underwriting, one fintech startup is betting on those who fall through the cracks. GradBridge, a Delaware-based student lending company, has raised $20 million in Series A funding to support the launch of its unique “second-look” private student loan product—aimed squarely at students who’ve…
In the complex world of immune-mediated diseases, where treatment options often fall short, Electra Therapeutics is carving a distinct path. The late-stage biotech, based in the U.S., has secured a robust $183 million in Series C funding to advance its groundbreaking precision therapies targeting severe immunological conditions and hematologic cancers. The financing round, co-led by…
Knack, a student‑success platform that enables higher‑education institutions to manage and expand peer‑learning programs, has closed a Series B round led by New Markets Venture Partners (NMVP), and simultaneously appointed Megan Dusenbery as Chief Executive Officer, while founder Samyr Qureshi transitions to Executive Chairman of the Board. Founded in 2015, Knack has partnered with major institutions—such as Fordham University, Northeastern University, the University of Florida…
In an era where data is the new currency, customer research remains a stubborn bottleneck for many enterprises. The traditional process—laden with weeks of manual interviews and analysis—often leaves product teams and strategists waiting too long to act. Enter Strella, an AI-powered customer research platform that is rewriting this narrative with a bold vision: making…
Irys, a Tampa‑based insurtech, has closed a $12.5 million seed round led by Markd, with backing from Deepwork Capital, Florida Opportunity Fund, Ansay & Associates, HICO Ventures, and JMG Capital. The new capital will accelerate engineering hiring, deployment of its platform across U.S. and Canadian markets, and further integrations with distribution partners. At the heart…
EVerZom, a pioneering biotechnology firm based in France, has secured €10 million in a Series A funding round to propel the clinical development of its first therapeutic candidate and further scale its exosome biomanufacturing platform. The investment, which brings together major players like Capital Grand Est, the European Innovation Council (EIC) Fund, Sorbonne Venture by…
Founded in 2021, Unfabled has swiftly evolved from a niche online startup into one of the UK’s fastest-growing women’s healthcare brands. Spearheaded by Founder and CEO Hannah Samano, the brand announced a $1.7 million (£1.15 million) funding round that pushes its total seed investment to $3.9 million (£3.2 million). Complementing this financial boost, Unfabled’s products…
In a decisive move to globalize its leadership and ambitions, South Korean aesthetics major Hugel Inc. has appointed Carrie Strom, a seasoned US pharmaceutical executive, as its President and Global Chief Executive Officer, effective immediately. This marks the creation of a newly formed global CEO position at Hugel—one that signals a shift from domestic dominance…
As neurological disorders like Parkinson’s and dementia surge globally, healthcare systems are grappling with the growing challenge of timely diagnosis and sustained patient management. Enter Kneu Health, a precision neurology startup that is redefining how these conditions are monitored and managed—leveraging nothing more than a smartphone and sophisticated AI. With a freshly closed $5.6 million…
The Altitude Group has named Stéphanie Lynch-Habib as the new Managing Director of Covage, effective September 15, 2025, succeeding Aymeric de Cardes. Covage, France’s third-largest fibre optic infrastructure provider serving the wholesale business market, is set to enter a new phase of expansion under Lynch-Habib’s leadership. Acquired by the Altitude Group in 2021, Covage stands…
